Live Breaking News & Updates on Ambalal Sarabhai|Page 6

Stay updated with breaking news from Ambalal sarabhai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ambalal Sarabhai spurts after unit hikes production of Amphotericin B


Ambalal Sarabhai Enterprises (ASE) hit an upper circuit of 20% at Rs 33.40 after the company said that its subsidiary has ramped up the production of API Amphotericin B.
The company said that India is witnessing an outbreak of Mucormycosis - a very fast spreading fungal infection especially for post-COVID infection and recovery because of low immune system in the patients. The most recommended treatment for this infection is Amphotericin B injection.
Synbiotics, a subsidiary of ASE is the only manufacturer of the active pharmaceutical ingredient (API) Amphotericin B in India. Looking at the current outbreak of Mucormycosis and expected requirement, Synbiotics has ramped up the manufacturing capacity to meet the requirement of this most effective anti-fungal antibiotic in the post-COVID crisis. ....

Ambalal Sarabhai Enterprises , Capital Market , Sarabhai Family , Gujarati People , Indian Jains , States And Union Territories Of India , Indian People , Ambalal Sarabhai , Amphotericin B , Generic Pharmaceuticals , Ucormycosisa Very Fast Spreading Fungal , அம்பலால் சரபை நிறுவனங்கள் , மூலதனம் சந்தை ,